Inotiv Inc

Inotiv Inc. Q1 2026 results: modest $120.88 M revenue, a larger-than‑expected loss, but a strategic shift toward profitability with new CRO services and talent investment.

Inotiv Inc. is a contract research organization providing research and development resources to pharmaceutical, medical device, and biotechnology companies globally, despite facing recent financial challenges.

Inotiv Inc. is a pivotal player in the life sciences tools and services sector, providing essential research and development resources to pharmaceutical, medical device, and biotechnology companies globally.